Global Lumbar Disc Herniation Treatment Market – Industry Trends and Forecast to 2029

Market Analysis and Size

Almost 80% of the population will have low back pain (LBP) at least once in their lives. LBP costs the United States more than USD 100 billion per year due to its high prevalence and major contribution to disability. The most common cause of LBP is intervertebral degeneration, which results in degenerative disc disease and lumbar disc herniation (LDH). Lumbar disc herniation, which most usually affects the L4-L5 and L5-S1 levels, is a major cause of low back pain and radicular leg discomfort.

Data Bridge Market Research analyses that the lumbar disc herniation treatment market was valued at USD 2.568 million in 2021 and is expected to reach USD 4.16 million by 2029, registering a CAGR of 6.20% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Report Scope and Market Segmentation

Market Definition

Lumbar disc herniation (LDH) is a frequent low back condition. It's one of the most frequent disorders that causes low back and/or leg discomfort in people. A herniated disc occurs when disc material (nucleus pulposus or annulus fibrosis) is displaced outside the intervertebral disk's region. This herniation cycle begins with failure in the innermost annulus rings and moves radially outward. Damage to the annulus of the disc is commonly related with totally flexing the spine over an extended period of time.

Lumbar Disc Herniation Treatment Market Dynamics

Drivers

• High prevalence rate of smoking

The rise in prevalence rate of smoking will act as a major driver that will result in the expansion of the growth rate of the market. Smoking is thought to reduce the oxygen flow to discs, causing them to break down faster and hence will further cushion the growth rate of lumbar disc herniation treatment market.

• Sedentary lifestyle of people

The increasing prevalence of sedentary lifestyle among people such as lack of physical exercise is the major reason which is estimated to enhance the market’s growth rate during the forecast period of 2022-2029. Back problems are more common among people who work in physically demanding jobs. Lifting, pushing, twisting repeatedly, tugging, and bending laterally, can also lead to a herniated disc.

• Increasing investment for healthcare infrastructure

Another significant factor influencing the growth rate of lumbar disc herniation treatment market is the rising healthcare expenditure which helps in improving its infrastructure. Also, various government organizations aims to improve the healthcare infrastructure by increasing funding and this will further influence the market dynamics.

Furthermore, rising initiatives by public and private organizations to spread awareness will expand the lumbar disc herniation treatment market. Additionally, introduction and swift adoption related to the technologically advanced medical devices and surging geriatric population will result in the expansion of lumbar disc herniation treatment market.

 Opportunities

• Increase in the number of research and development activities       

Moreover, the market's growth is fueled by an increase in the number of research and development activities. This will provide beneficial opportunities for the lumbar disc herniation treatment market growth. Along with this, rising drug approvals and launches will further propel the market’s growth rate.

Moreover, rising investment for the development of advanced technologies and increase in the number of emerging markets will further provide beneficial opportunities for the lumbar disc herniation treatment market growth during the forecast period.

Restraints/Challenges

On the other hand, high cost associated with the treatment will obstruct the growth rate of market. The lack of healthcare infrastructure in developing economies and the dearth of skilled professionals will challenge the lumbar disc herniation treatment market. Additionally, strict food and drug administration (FDA) guidelines for approving new medication and lack of awareness about the treatment will act as restrain and further impede the growth rate of market during the forecast period of 2022-2029.

This lumbar disc herniation treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the lumbar disc herniation treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Patient Epidemiology Analysis

Lumbar disc herniation treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

COVID-19 Impact on Lumbar Disc Herniation Treatment Market

During the COVID-19 outbreak, the patient's condition in both the spinal outpatient and emergency departments has reached a critical stage, with a level of seriousness well above normal. Individuals have experienced anxiety disorders as a result of the COVID 19 pandemic, which was exacerbated by the epidemic's loneliness. Excessive concern about their health, illness, and contracting the coronavirus has resulted in an increase in hospital visits. To combat these difficulties, governments are investing in infrastructure connected to slipped disc issues, as well as the development of the COVID 19 vaccine and treatment.

Global Lumbar Disc Herniation Treatment Market Scope

The lumbar disc herniation treatment market is segmented on the basis of type, location type, treatment, diagnosis, dosage form, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Location Type

• Axillary
• Foraminal
• Posterolateral
• Central Prolapse

Diagnosis

• Nerve Tests
• Electromyography (EMG)
• Nerve conduction study
• Imaging Tests
• Magnetic resonance imaging (MRI)
• Myelogram
• Computerized tomography (CT) scan
• X-rays
• Others

Treatment

• Medication
• Non-steroidal anti-inflammatory drugs (NSAIDs)
• Opioids
• Muscle relaxers
• Local corticosteroid injections (CSI)
• Surgery
• Far lateral microdiskectomy
• Laminotomy and discectomy
• Physical Therapy
• Others

Type

• Chronic
• Acute

Dosage Form

• Injection
• Tablets
• Others

Route of Administration

• Parenteral
• Oral
• Others

End-Users

• Hospitals
• Specialty Clinics
• Homecare
• Others

Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Others

Lumbar Disc Herniation Treatment Market Regional Analysis/Insights

The lumbar disc herniation treatment market is analysed and market size insights and trends are provided by country, type, location type, treatment, diagnosis, dosage form, route of administration, end-users and distribution channel as referenced above.

The countries covered in the lumbar disc herniation treatment market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

North America dominates the lumbar disc herniation treatment market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the presence of major key players and rising healthcare expenditure will further propel the market’s growth rate in this region.

Asia-Pacific are expected to grow during the forecast period of 2022-2029 due to surging prevalence of lumbar disc herniation in this region. Also, development of healthcare infrastructure and growing government initiatives will further propel the market’s growth rate in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Lumbar Disc Herniation Treatment Market Share Analysis

The lumbar disc herniation treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to lumbar disc herniation treatment market.

Some of the major players operating in the lumbar disc herniation treatment market are:

• Pfizer Inc. (US)
• GlaxoSmithKline plc (UK)
• Novartis AG (Switzerland)
• Mylan N.V. (US)
• Teva Pharmaceutical Industries Ltd. (Israel)
• Sanofi (France)
• Boehringer Ingelheim International GmbH. (Germany)
• AstraZeneca (UK)
• Johnson & Johnson Private Limited (US)
• Merck & Co., Inc. (US)
• F. Hoffmann-La Roche Ltd. (Switzerland)
• Sun Pharmaceutical Industries Ltd. (India)
• Aurobindo Pharma (India)
• Zydus Cadila (India)
• NuVasive, Inc. (US)
• Globus Medical (US)
• Zimmer Biomet (US)
• Medtronic (Ireland)
• Stryker (US)
• Assertio Therapeutics, Inc. (US) 

SKU-56397